Zydus Lifesciences Ltd.
Snapshot View

424.60 +1.35 ▲0.3%

07 October 2022, 11:55:59 AM
Volume: 940,009

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zyduscadila.com
Market Cap 42,704.89 Cr.
Enterprise Value(EV) 45,920.52 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 43.65 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 9.67 Trailing Twelve Months Ending 2022-06
Industry PE 32.07 Trailing Twelve Months Ending 2022-06
Book Value / Share 166.09 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.54 Calculated using Price: 421.90
Dividend Yield 0.59 Period Ending 2022-03
No. of Shares Subscribed 101.22 Cr. 1,012,204,139 Shares
FaceValue 1
Company Profile
The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products. Innovation is the backbone of the company as it ensures business sustainability through continuous availability of new products for various businesses.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.32%
1 Week
+9.74%
1 Month
+12.88%
3 Month
+15.54%
6 Month
+15.02%
1 Year
-22.76%
2 Year
+2.85%
5 Year
-15.03%
10 Year
+159.09%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 26.20 30.85 38.62 23.43 22.26 19.36 11.32 18.88 15.51
Return on Capital Employed (%) 17.67 23.21 28.60 16.50 18.41 15.89 10.02 14.23 15.30
Return on Assets (%) 10.89 13.93 20.14 12.18 11.11 9.34 5.18 9.66 9.40

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 2,945 3,439 4,252 5,699 6,960 8,745 10,386 10,376 12,992 17,000
Non Curr. Liab. 1,640 1,589 1,342 736 1,903 2,122 3,491 2,854 19 -194
Curr. Liab. 2,670 2,814 3,285 3,461 5,306 6,083 7,343 8,269 7,861 7,839
Minority Int. 119 144 169 136 156 191 1,293 1,335 1,937 2,054
Equity & Liab. 7,374 7,987 9,047 10,032 14,325 17,141 22,513 22,834 22,810 26,700
Non Curr. Assets 4,183 4,549 4,820 5,752 8,303 8,911 14,015 14,118 14,094 14,438
Curr. Assets 3,192 3,438 4,227 4,280 6,022 8,230 8,498 8,715 8,716 12,261
Misc. Exp. not W/O
Total Assets 7,374 7,987 9,047 10,032 14,325 17,141 22,513 22,834 22,810 26,700

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 7,224 8,651 9,427 9,377 11,955 13,166 14,253 14,404 15,265 15,376
Other Income 86 57 117 147 133 209 117 47 235 259
Total Income 7,310 8,709 9,543 9,524 12,088 13,374 14,370 14,451 15,501 15,635
Total Expenditure -6,031 -6,897 -7,097 -7,475 -9,126 -10,187 -11,473 -11,018 -11,935 -12,212
PBIDT 1,279 1,811 2,446 2,049 2,962 3,187 2,897 3,433 3,565 3,423
Interest -118 -68 -53 -63 -111 -196 -342 -159 -127 -134
Depreciation -201 -287 -292 -373 -539 -599 -697 -670 -713 -734
Taxation -106 -259 -177 -129 -564 -530 -320 -194 -512 -438
Exceptional Items -17 -10 -3 0 -10 -364 -205 113 -99
PAT 836 1,186 1,921 1,483 1,748 1,852 1,176 2,206 2,326 2,018
Minority Interest -33 -38 -30 -29 -35 -50 -28 -51 -131 -134
Share Associate 43 34 63 47 29 47 46 61
Other Related Items
Consolidated Net Profit 804 1,151 1,934 1,488 1,776 1,849 1,177 2,134 4,487 4,418
Adjusted EPS 8 11 19 15 17 18 11 21 44 43

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 603 903 994 1,894 1,312 919 1,282 2,932 3,294 2,104
Cash Fr. Inv. -682 -438 -465 -864 -2,872 -974 -4,239 -1,012 -725 1,154
Cash Fr. Finan. 286 -529 -351 -935 2,316 52 1,885 -1,528 -2,548 -868
Net Change 207 -64 178 95 756 -3 -1,072 391 22 2,390
Cash & Cash Eqvt 677 613 790 837 1,593 1,590 779 1,178 1,087 3,460

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 74.88 74.88 74.88 74.88 74.88 74.88 74.88 74.88 74.88
Public 25.12 25.12 25.12 25.12 25.12 25.12 25.12 25.12 25.12
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 06 Oct 2022
General updates
Zydus Lifesciences Limited has informed the Exchange about Compliance Certificate under regulation 74(5) of DP Regulations
Thu, 06 Oct 2022
Loss of share certificate
Zydus Lifesciences Limited has informed the Exchange about Loss of share certificate
Thu, 06 Oct 2022
Press Release
Zydus Lifesciences Limited has informed the Exchange about press release dated 06-Oct-2022 titled Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets

Technical Scans View Details >>

Thu, 06 Oct 2022
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days
Making Higher Highs for 3 days Making Higher Highs for 3 days
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Increase 1 Month High Increase 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 952.25 -0.2%
Divi's Laboratories Ltd. 99,171.10 3,721.50 -0.3%
Cipla Ltd. 91,534.16 1,136.60 +0.2%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,383.10 -0.3%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. 54,354.34 1,593.55 -0.7%
Max Healthcare Institute Ltd. 41,351.89 412.30 -3.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 952.25 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,721.50 -0.3%
Cipla Ltd. Consolidated 2022-06 36.78 1,136.60 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,383.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,593.55 -0.7%
Max Healthcare Institute Ltd. Consolidated 2022-06 65.54 412.30 -3.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 952.25 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,721.50 -0.3%
Cipla Ltd. Consolidated 2022-06 4.26 1,136.60 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,383.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,593.55 -0.7%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.43 412.30 -3.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 952.25 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,721.50 -0.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,136.60 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,383.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,593.55 -0.7%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 412.30 -3.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 952.25 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,721.50 -0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,136.60 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,383.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,593.55 -0.7%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 412.30 -3.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 952.25 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,721.50 -0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,136.60 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,383.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,593.55 -0.7%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 412.30 -3.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 952.25 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,721.50 -0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,136.60 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,383.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,593.55 -0.7%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 412.30 -3.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 952.25 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,721.50 -0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,136.60 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,383.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,593.55 -0.7%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 412.30 -3.3%

FAQ's On Zydus Lifesciences Ltd.

What is Zydus Lifesciences share price?

Can I buy Zydus Lifesciences shares now?

What is the Dividend Yield of Zydus Lifesciences?

What is the Market Cap of Zydus Lifesciences?

What are the key metrics to analyse Zydus Lifesciences?

What is the 52 Week High and Low of Zydus Lifesciences?

What is the trend of Zydus Lifesciences share price?